"Kari Appachu, MD Basel Channis, MD Vikas Kalra, MD Divya Malladi, MD Pradeep Mehra, MD Clyde Mendonca, MD Stephen Schinker, MD Theodore Tzeremas, MD"

During the past decade, Southwest Kidney Institute, PLC conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Southwest Kidney Institute, PLC" are "Chronic Kidney Disease, Stage 5" (1 trials) and "Polycystic Kidney, Autosomal Dominant" (1 trials). Many other conditions were trialed in "Southwest Kidney Institute, PLC" in a lesser frequency.

Most popular intervention types in "Southwest Kidney Institute, PLC" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Bosutinib" (1 trials), "Fosrenol (Lanthanum Carbonate)" (1 trials), "Placebo" (1 trials) and "Sevelamer hydrochloride" (1 trials). Other intervention names were less common.

The vast majority of trials in "Southwest Kidney Institute, PLC" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Southwest Kidney Institute, PLC". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Southwest Kidney Institute, PLC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Southwest Kidney Institute, PLC, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".